Literature DB >> 6381264

Effect of orally administered food-grade carrageenans on antibody-mediated and cell-mediated immunity in the inbred rat.

S Nicklin, K Miller.   

Abstract

Experiments were performed to investigate the immunological consequences associated with the persorption of poorly degradable carregeenans from the diet. Using an inbred strain of rat it was demonstrated histochemically, by the carrageenan-specific Alcian blue staining technique, that small quantities of food-grade carrageenans given at 0.5% in drinking-water for 90 days could penetrate the intestinal barrier of adult animals. This apparently occurred via an intact mucosa in the absence of inflammatory or pathological lesions. The carrageenan was demonstrated in macrophage-like cells present within the villi and lamina propria of the small intestine. The oral administration of kappa, lambda or iota food-grade carrageenans did not affect local (biliary) or systemic antibody responses to gut commensal microorganisms, or to orally-administered sheep erythrocytes. However, when sheep red blood cells were administered parenterally the ensuing anti-sheep red blood cell haemagglutinating antibody response was temporarily suppressed in carrageenan-fed rats. lambda-Carrageenan and iota-carrageenan both significantly (P less than or equal to 0.01 and P less than or equal to 0.05, respectively) reduced the mid-phase (14-28 days) haemagglutinin response; kappa-carrageenan (L100) was less effective but caused significant depression at day 21 (P less than or equal to 0.01). Individual responses were, however, within the control range 35 days after sheep erythrocyte administration, thus indicating the temporary nature of this effect. Although carrageenan administration depressed the anti-sheep erythrocyte antibody response, it did not affect T-cell immune competence as measured by the popliteal lymph node assay for graft-versus-host reactivity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381264     DOI: 10.1016/0278-6915(84)90270-9

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

Review 1.  Toxicological properties of carrageenan.

Authors:  M L Weiner
Journal:  Agents Actions       Date:  1991-01

2.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

3.  Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Model development, histopathology, and effects of sulfasalazine.

Authors:  P Oestreicher; S T Nielsen; K D Rainsford
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

Review 4.  Review of harmful gastrointestinal effects of carrageenan in animal experiments.

Authors:  J K Tobacman
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

Review 5.  Intestinal Macromolecular Transport Supporting Adaptive Immunity.

Authors:  Devesha H Kulkarni; Rodney D Newberry
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-01-30

6.  Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats.

Authors:  Rajan Radhakrishnan; Steven A Moore; Kathleen A Sluka
Journal:  Pain       Date:  2003-08       Impact factor: 7.926

7.  Molecular basis of carrageenan-induced cytokines production in macrophages.

Authors:  Alexandre H Lopes; Rangel L Silva; Miriam D Fonseca; Francisco I Gomes; Alexandre G Maganin; Lucas S Ribeiro; Lucas Maciel Mauriz Marques; Fernando Q Cunha; Jose C Alves-Filho; Dario S Zamboni; Norberto P Lopes; Bernardo S Franklin; Aurélie Gombault; Fernando Silva Ramalho; Valerie F J Quesniaux; Isabelle Couillin; Bernhard Ryffel; Thiago M Cunha
Journal:  Cell Commun Signal       Date:  2020-09-07       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.